Himadri Speciality Chemical Q2 FY25 earnings call: Revenue & Margins
Q2 FY25 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹1,137Cr
- +13.1% YoY
- −5.2% QoQ
- Net profit
- ₹136Cr
- +34.7% YoY
- +10.6% QoQ
- Margin
- 18%
- +2 pp YoY
- +2 pp QoQ
Guidance rank: #19 of 70 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
Himadri Speciality Chemical Ltd Q2 FY25 key numbers
- Revenue
- Standalone Net Revenue from Operations for Q2FY25: Rs. 1,135.21 Cr, up 13.01% YoY.
As stated in Himadri Speciality Chemical Ltd's Q2 FY25 investor presentation · published 25 Sept 2026. Reported figures, not investment advice.
Based on Himadri Speciality Chemical Ltd's Q2 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Standalone Net Revenue from Operations for Q2FY25: Rs. 1,135.21 Cr, up 13.01% YoY (Page 45). EBITDA (Standalone, Q2 FY25): Rs. 201.35 Cr, up 29.1% YoY (from Rs. 156.00 Cr in Q2 FY24).
From Himadri Speciality Chemical Ltd's Q2 FY25 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
- Standalone Net Revenue from Operations for Q2FY25: Rs. 1,135.21 Cr, up 13.01% YoY (Page 45)
- Consolidated Net Revenue from Operations for Q2FY25: Rs. 1,136.92 Cr, up 13.18% YoY (Page 46)
- Sales Volume for Q2FY25: 139,057 MT, up 26.2% YoY (Page 6)
2 more points from Himadri Speciality Chemical Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Himadri Speciality Chemical Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Capex for first commercial plant of 40,000 MTPA LFP Cathode Active Material: Rs. 1,125 crores; progressing as planned; operational by Q3FY27 (Page 11).
- Expansion of speciality carbon black line by 70,000 MTPA: Rs. 220 crores; scheduled operational by Q3FY26 (Pages 11, 24).
- Increasing total speciality carbon black capacity to 130,000 MTPA, making it the world’s largest single-site capacity (Page 24).
- Acquisition of plant by Himadri Speciality Chemical Ltd: total cost Rs. 306 crores; additional capex needed to make plant fully operational; organic creation would take 36 months (Page 33).
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Himadri Speciality Chemical Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Himadri Speciality Chemical Ltd — Quarterly revenue & net profit
Himadri Speciality Chemical Ltd Q2 FY25 results — key figures
| ₹ Cr | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue | 1,137 | 1,005 | +13.1% | 1,200 | -5.2% |
| Operating profit (EBITDA) | 208 | 158 | +31.6% | 192 | +8.3% |
| Operating margin | 18% | 16% | +2 pp | 16% | +2 pp |
| Profit before tax | 197 | 139 | +41.7% | 179 | +10.1% |
| Net profit (PAT) | 136 | 101 | +34.7% | 123 | +10.6% |
| EPS (₹) | 2.74 | 2.29 | +19.7% | 2.48 | +10.5% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹1.7K Cr, net profit ₹231 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Himadri Special's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Vidhi Specialty (Q2 FY25)
Year-on-Year (Y-o-Y) growth: 13.9% (Page 8) . Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q2 FY25 earnings call — and how it ranks…
- Chemcon Speciality Chemicals (Q2 FY25)
30% YoY). Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q2 FY25 earnings call — and how it ranks against sector peers.
- Valiant Organics (Q2 FY25)
Consolidated: INR 1,602 Mn (down 21.1% YoY from INR 2,031 Mn in Q2-FY24) . Key concall takeaways from Valiant Organics Ltd's Q2 FY25 earnings call — and how it…
- Excel Industries (Q2 FY25)
Q2 FY25 standalone revenue from operations: ₹269 crore, up 1.51% QoQ from Q1 FY25 (₹265 crore). Key concall takeaways from Excel Industries Ltd's Q2 FY25…
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Himadri Speciality Chemical Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Himadri Speciality Chemical Ltd Q2 FY25 results?
Standalone Net Revenue from Operations for Q2FY25: Rs. 1,135.21 Cr, up 13.01% YoY (Page 45). EBITDA (Standalone, Q2 FY25): Rs. 201.35 Cr, up 29.1% YoY (from Rs. 156.00 Cr in Q2 FY24).
What is Himadri Speciality Chemical Ltd share price analysis?
Himadri Speciality Chemical Ltd currently shows a neutral. The stock trades at a P/E of 42.6 with a market cap of ₹34,076 Cr. Investors should review the full earnings analysis for detailed insights.
Is Himadri Speciality Chemical Ltd planning capital expenditure?
Capex for first commercial plant of 40,000 MTPA LFP Cathode Active Material: Rs. 1,125 crores; progressing as planned; operational by Q3FY27 (Page 11).
Keep Himadri Speciality Chemical Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
